Results 101 to 110 of about 13,254 (218)

β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development

Pathogens
Antimicrobial resistance remains a public health problem of global concern with a great health and financial burden. Its recognition as a threat by political leadership has boosted the research and development of new antibiotics and particularly novel ...
Angeliki Katsarou, Panagiotis Stathopoulos, Iva D. Tzvetanova, Christina-Maria Asimotou, Matthew E. Falagas   +4 more
doaj   +1 more source

Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin [PDF]

, 1996
M Dreetz, Jürg Hamacher, J Eller, K. Börner, P. Koeppe, T. Schaberg, H. Lode   +6 more
openalex   +1 more source

Real-World Experience of Imipenem–Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study)

Infectious Diseases and Therapy
Introduction Difficult-to-treat-resistant (DTR) infections caused by Pseudomonas aeruginosa represent a global public health threat, prioritizing the search and development of new antibiotics for this microorganism.
Isabel Machuca, Arantxa Dominguez, Rosario Amaya, Cristina Arjona, Irene Gracia-Ahufinger, Maravillas Carralon, Rosa Giron, Isabel Gea, Natividad De Benito, Andres Martin, Fatima Galan, Jose Antonio Martinez, Rayden Iglesias, Jaume Revuelto, Juan Jose Caston, Angela Cano, Elisa Ruiz-Arabi, Luis Martínez-Martínez, Julian Torre-Cisneros   +18 more
doaj   +1 more source

Neurotoxicity due to imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis [PDF]

, 1999
Maite Rivera
openalex   +1 more source

Effects of Cilastatin on the Pharmacokinetics of a New Carbapenem, DA-1131, in Rats, Rabbits, and Dogs [PDF]

, 1999
So H. Kim, Jong Won Kwon, Won B. Kim, Myung G. Lee   +3 more
openalex   +1 more source

Empiric Imipenem/Cilastatin/Relebactam for Febrile Neutropenia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports

Journal of Blood Medicine
Dao-Xing Deng,* Ting Wang,* Hui Sun,* Jun Kong, Yuan-Yuan Zhang, Le-Qing Cao, Xiao-Dong Mo Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center
Deng DX, Wang T, Sun H, Kong J, Zhang YY, Cao LQ, Mo XD   +6 more
doaj  

Pseudomonas sepsis with neutrophagocytosis in a premature newborn

The Turkish Journal of Pediatrics, 2000
Secondary hemophagocytic syndrome may develop during certain severe infections commonly due to viral infections, but is rarely associated with bacterial infections, and its appearance in a premature newborn is uncommon.
D Aliefendioğlu, D Aslan, G Tekinalp, A Gürgey   +3 more
doaj  

Abstract No. 14 Characteristics of imipenem–cilastatin as a temporary embolic agent for genicular artery embolization [PDF]

, 2021
Neeral R. Patel, Sidney L. Penner, Naomi Matsuura, Sebastian Mafeld   +3 more
openalex   +1 more source

Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury [PDF]

, 1996
Satoru Hashimoto, Erika J. Wolfe, B. Joseph Guglielmo, Robert M. Q. Shanks, Jon G. Sundelof, Jean‐François Pittet, Emily Thomas, Jeanine P. Wiener-Kronish   +7 more
openalex   +1 more source

Erratum to: Imipenem/Cilastatin [PDF]

, 1992
Micaela N. Buckley, Rex N. Brogden, Lee B. Barradell, Karen L. Goa   +3 more
openalex   +1 more source